Notably, IGF2BP1 facilitates the translation of circMAP3K4 into a novel peptide of 63 kDa, circMAP3K4-455aa, which inhibits the apoptosis of HCC cells. Here, IGF2BP1 is linked to hepatocellular carcinoma.